GlobalData on MSN
TransMedics receives IDE approval from FDA for OCS Heart trial
The total number of patients enrolled across both parts is anticipated to exceed 650.
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...
Heart transplantation using organs obtained from donors with circulatory death (DCD) is associated with transient right-heart dysfunction but offers short-term clinical outcomes otherwise comparable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results